Jenscare Scientific Co., Ltd.

Jenscare Scientific is a China-based medical device company specializing in the research, development, and commercialization of minimally invasive interventional products for the treatment of structural heart diseases. Its portfolio targets conditions such as tricuspid valve disease, aortic valve disease, mitral valve disease, heart failure, and cardiogenic stroke. The company is focused on global expansion and commercialization of its proprietary technologies, including the LuX-Valve series for tricuspid regurgitation and the Ken-Valve system for aortic regurgitation. Listed on the Hong Kong Stock Exchange, Jenscare operates with a focus on high-risk patient populations and advanced interventional solutions.